Business
ODIN: Revenue declined and losses continued, but clinical and technical milestones were achieved
ODIN: Revenue declined and losses continued, but clinical and technical milestones were achieved
About this update from Odinwell Ab
Revenue and net results declined year-over-year, with continued negative operating results. Key milestones included progress in clinical pilot studies and a successful rights issue, supporting ongoing R&D and product industrialization.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.